Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FNA Tumor Sampling for CD137 Modulation: A Pilot Study

NCT01114256 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01114256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FNA Tumor Sampling for CD137 Modulation: A Pilot Study
Lead sponsor
Stanford University
Phase
Observational
Overall status
Terminated
Start date
March 31, 2010
Completion date
January 31, 2016
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal adenocarcinoma, head and neck cancer, head and neck cancers, non-hodgkin lymphoma